HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Long-term outcome in patients with ductal carcinoma in situ treated with breast-conserving therapy: implications for optimal follow-up strategies.

AbstractPURPOSE:
To determine 20-year rates of local control and outcome-associated factors for ductal carcinoma in situ (DCIS) after breast-conserving therapy (BCT).
METHODS AND MATERIALS:
All DCIS cases receiving BCT between 1980 and 1993 were reviewed. Patient demographics and pathologic factors were analyzed for effect on outcomes, including ipsilateral breast tumor recurrence (IBTR) and survival.
RESULTS:
One hundred forty-five cases were evaluated; the median follow-up time was 19.3 years. IBTR developed in 25 patients, for 5-, 10-, 15-, and 20-year actuarial rates of 9.9%, 12.2%, 13.7%, and 17.5%, respectively. One third of IBTRs were elsewhere failures, and 68% of IBTRs occurred <10 years after diagnosis. Young age and cancerization of lobules predicted for IBTR at <10 years, and increased slide involvement and atypical ductal hyperplasia were associated with IBTR at later time points.
CONCLUSIONS:
Patients with DCIS treated with BCT have excellent long-term rates of local control. Predictors of IBTR vary over time, and the risk of recurrence seems highest within 10 to 12 years after diagnosis.
AuthorsSimona F Shaitelman, J Ben Wilkinson, Larry L Kestin, Hong Ye, Neal S Goldstein, Alvaro A Martinez, Frank A Vicini
JournalInternational journal of radiation oncology, biology, physics (Int J Radiat Oncol Biol Phys) Vol. 83 Issue 3 Pg. e305-12 (Jul 01 2012) ISSN: 1879-355X [Electronic] United States
PMID22417804 (Publication Type: Journal Article)
CopyrightCopyright © 2012 Elsevier Inc. All rights reserved.
Topics
  • Adult
  • Age Factors
  • Analysis of Variance
  • Axilla
  • Breast Neoplasms (diagnostic imaging, mortality, pathology, radiotherapy, surgery)
  • Carcinoma, Intraductal, Noninfiltrating (diagnostic imaging, mortality, pathology, radiotherapy, surgery)
  • Combined Modality Therapy (methods)
  • Female
  • Follow-Up Studies
  • Humans
  • Lymph Node Excision
  • Mastectomy, Segmental
  • Middle Aged
  • Neoplasm Recurrence, Local (diagnostic imaging, mortality, radiotherapy, surgery)
  • Neoplasms, Second Primary (diagnostic imaging, mortality, radiotherapy, surgery)
  • Radiography
  • Radiotherapy Dosage
  • Retrospective Studies
  • Risk Assessment
  • Salvage Therapy (methods)
  • Survival Analysis
  • Time Factors
  • Tumor Burden

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: